PIRADS

The Prostate Imaging Reporting and Data System, commonly known as PIRADS, is a standardized reporting system used in the interpretation of multiparametric magnetic resonance imaging (mpMRI) of the prostate. Developed by the American College of Radiology (ACR), PIRADS aims to improve the accuracy and consistency of prostate cancer detection, localization, and risk stratification. It categorizes suspicious lesions identified on mpMRI into five categories, from PIRADS 1 (very low likelihood of clinically significant cancer) to PIRADS 5 (very high likelihood of clinically significant cancer).

Each PIRADS category is based on a combination of features observed on different MRI sequences, including T2-weighted imaging, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE) imaging. The system provides a structured approach for radiologists to assess and report findings, facilitating better communication between radiologists, urologists, and other clinicians involved in prostate cancer management. A PIRADS 3 score indicates an intermediate likelihood of cancer, often necessitating further investigation such as a targeted biopsy.

The primary goal of PIRADS is to help differentiate between clinically significant prostate cancers that require treatment and indolent cancers that may not. By standardizing the reporting of mpMRI findings, PIRADS can aid in reducing unnecessary biopsies and improving the detection of aggressive tumors. The system is continuously updated based on emerging research and clinical experience to enhance its performance and utility in the diagnosis and management of prostate cancer.